FPGEE for National Association of Boards of Pharmacy (NABP) Practice Exam 2025 - Free NABP Practice Questions and Study Guide

Records of Schedule V drugs must be maintained for two years from the date of the last transaction. This requirement aligns with federal regulations governing controlled substances, which specify the retention period for records associated with the dispensing and distribution of these drugs. Schedule V substances, while considered to have a lower potential for abuse compared to higher schedules, still require careful record-keeping to ensure proper accountability and to assist in regulatory audits.

Maintaining these records for a two-year period helps healthcare providers, pharmacists, and regulatory agencies track the distribution and usage patterns of Schedule V drugs, ensuring compliance with the law and facilitating the identification of any potential misuse. The other retention periods mentioned are not applicable to Schedule V substances under federal regulations, as they are more aligned with different categories or specific requirements for certain healthcare practices.